|Bid||0.00 x 1200|
|Ask||0.00 x 3000|
|Day's range||89.62 - 92.86|
|52-week range||18.83 - 138.52|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||10 Aug 2021 - 16 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||109.83|
If you're looking to take that same path, healthcare stands out as one of the biggest market opportunities around. Here are three healthcare stocks that could make you rich over the next decade. Beam Therapeutics (NASDAQ: BEAM) is the pioneering leader in genomic base editing.
After rallying on the coattails of Intelllia's breakthrough, these companies have given back their June gains.
Shares of Beam Therapeutics (NASDAQ: BEAM) jumped almost 65% last month according to S&P Global Market Intelligence. The move was in concert with other gene editing companies after Intellia Therapeutics and Regeneron announced results from a phase 1 study. The data indicated the pair had successfully used CRISPR-Cas9 to treat a rare liver disease.